Challenging Big Pharma: Patent Evergreening and Accessibility in Tuberculosis Treatment

This chapter examines the critical issue of patent evergreening in the pharmaceutical industry, highlighting Johnson & Johnson's case with the tuberculosis drug bedaquiline. It discusses the impact of releasing patents on drug accessibility and covers ongoing challenges in reducing prices for tuberculosis testing.